Rationale Endocannabinoids have emerged as a modulatory brain system affecting different types of synapses, broadly distributed throughout the CNS, which explain the diverse psychophysical effects observed following activation of the endocannabinoid system. Objectives and methods The present study aimed to characterize the effect of CB1-mediated activity in the visual thalamus. In vivo single-unit extracellular recordings were performed in anaesthetized adult pigmented rats, measuring visual and spontaneous activity, combined with application of CB1 receptor agonists (anandamide, 2-AG, and O2545) and one antagonist, AM251. Results CB1 receptors activation revealed two cellular populations, with excitatory effects on ∼28% of cells and inhibitory in ∼72%, actions which were blocked by the antagonist AM251. The agonist action significantly altered both spontaneous and visual activity, shifting the signal-tonoise ratio (S/N), with accompanying changes in the variability within the visual response. Increased responses by agonist application were accompanied by a decrease in S/N and an increase in variability, while those cells inhibited by the agonist showed an increase in S/N and a decrease in variability. There was no obvious correlation between the two effects and any other response property suggesting a more general role in modulating all information passing from LGN to cortex. Conclusions Our data support a role for CB1 at the level of the thalamus acting as a dynamic modulator of visual information being sent to the cortex, apparently maintaining the salience of the signal within upper and lower boundaries. This may account for some of the behavioral effects of cannabis.
Introduction
The endocannabinoid system utilizes two well-characterized endogenous agonists, arachidonyl ethanolamide (anandamide, AEA) and sn-2 arachidonyl glycerol (2-AG) (Devane et al. 1992; Mechoulam et al. 1995; Sugiura et al. 1995) operating on two G-protein-coupled receptors, CB1 and CB2 (Matsuda et al. 1990; Munro et al. 1993) .
AEA and 2-AG are arachidonic acid derivatives stored as fatty acid components of membrane phospholipids (Di Marzo et al. 1994; Stella et al. 1997 ). Both ligands are released "on demand" by phosphorylation, following a depolarization-mediated increase in intracellular calcium (Sugiura et al. 1996; Stella et al. 1997) . The main receptors involved in AEA and 2-AG depolarization-mediated synthesis and release are mAChRs and group I mGluRs (Kim et al. 2002; Maejima et al. 2001 ), two of the major neurotransmitters involved in thalamic visual processing.
In the brain, AEA and 2-AG have been shown to have modulatory effects, acting presynaptically on CB1 receptors and, mainly, inhibiting neurotransmitter release (Freund et al. 2003 ). This effect is more prominent in GABAergic and glutamatergic transmission (Schlicker and Kathmann 2001; Piomelli 2003) , and has been well described in the hippocampus and cerebellum, where endocannabinoids mediate depolarization-induced suppression of inhibition (DSI) and depolarization-induced suppression of excitation (DSE) by inhibiting GABAergic and glutamatergic neurotransmission, respectively (Wilson and Nicoll 2001; Diana et al. 2002) . CB1 activation can also increase release of glutamate (Ferraro et al. 2001) or ACh (Acquas et al. 2000) in a dose-dependent manner in cerebral cortex and hippocampus.
In the visual system, there are well-documented psychotropic effects of Δ 9 -tetrahydrocannabinol (THC) which includes a reduction in Vernier and Snellen tests of acuity, and alterations of photosensitivity and color discrimination (Kiplinger et al. 1971; Dawson et al. 1977; Russo et al. 2004 ). To date, there have been no reported studies on the effects of endocannabinoids on visual processing at the level of the thalamus.
The dorsal lateral geniculate nucleus (dLGN) of the rat, as in cat and primate, is a dynamic relay station for visual information traveling from retina to cortex (Reese 1988; Sherman and Guillery 2002) . Surprisingly, the primary visual cortex is the major modulatory input to the dLGN in the form of glutamatergic feedback connections from layer VI of the cortex. The dLGN also receives modulatory cholinergic inputs from the parabrachial region of the midbrain and GABAergic modulation from local and thalamic reticular nucleus interneurons (Sherman and Guillery 2002) . Thus, the main neurotransmitters implicated in visual processing in dLGN are glutamate, GABA, and ACh that act over metabotropic and/or ionotropic receptors, all of which have previously been associated with endocannabinoid activity in other brain regions (Kim et al. 2002; Maejima et al. 2001; Haller et al. 2007) .
In the present study, we have recorded the activity of dLGN neurons extracellularly during spontaneous and visually driven conditions, in conjunction with manipulation of CB1 receptors.
Materials and methods

Animals and preparation
All experiments were carried out in Lister hooded adult rats of either sex weighing between 250 and 350 g. All procedures complied with the ethical use of animals specified in the European Communities Council Directive of November 24, 1986 (86/609/EEC) and Animals (Scientific Procedures) Act 1986, UK Home Office. We adopted previously published methods (Grieve 2005) , briefly outlined below, to perform the experiments. Animals were anaesthetized intraperitoneally with a mixture of ketamine+xylazine (50 mg kg −1 +10 mg kg −1 ) for induction and isoflurane in 50%O 2 :50%N 2 O for surgery and maintenance (1.0-2.0% surgery, 0.25-1.0% maintenance). To avoid eye movements, animals were paralyzed with gallamine triethiodide (20 mg kg −1 ) through the lateral tail vein and artificially respired. ECG, rectal temperature, and end-tidal CO 2 were measured and maintained continuously within normal physiological limits to ensure an appropriate level of anesthesia. Lidocaine gel was applied to pressure points and zero power contact lenses were placed in the eyes to protect the corneas. After each experiment, animals were killed with an anesthetic overdose without recovery from anesthesia. Animals were placed in a customized stereotaxic apparatus such that the head was secured in a horizontal orientation and the entire right visual hemifield was unobstructed. To access the left dLGN, the skull was exposed, a craniotomy was drilled ∼4.5 mm posterior to bregma and 3.5 mm lateral to the midline (Paxinos and Watson 1997) , and the dura mater was retracted with a curved needle.
Visual stimulation and recording
We used tungsten microelectrodes (FHC Inc.), multibarreled glass micropipettes [for iontophoresis; Harvard Apparatus, pulled on a Narishige PE-2electrode puller (Narishige, Japan), broken back under a light microscope to a tip diameter of 3-5 μm] or single-barreled glass micropipettes (for pressure ejection; tip diameter 10 μm) glued under a light microscope to a tungsten microelectrode with dental cement. To locate the dLGN, these were advanced into the brain using a hydraulic microdrive (Narishige) while stimulating the appropriate eye with hand-held stimuli. After reaching the dLGN, cells were first driven qualitatively to localize the receptive field position. Quantitative visual stimuli, consisted on flashing spots and sinusoidal moving gratings, were displayed monocularly and under computer control (Visage; CRS Ltd., UK) on a computer monitor centered in the receptive field and placed either 14 or 28 cm from the eye. Cell type (ON or OFF), receptive field size, and preferred spatial and temporal frequency were determined for each cell. It is important to note that each experimental protocol included both visually driven activity and equal periods of spontaneous activity, randomly interleaved.
The extracellular neural signal was continuously monitored on a 310 Tektronix Oscilloscope (Tektronix Holland N.V., The Netherlands) and audio monitor (FHC Inc.), amplified with a high-input impedance amplifier (AM System), voltage window discriminated, and fed into a computer via a digitizer interface (CED 1401 interface and Spike2 software; Cambridge Electronic Design, UK). Online analysis was carried out using custom-written Spike2 routines, and off-line with Spike2, MS Excel, and SPSS (SPSS Inc., Chicago, IL, USA).
Drugs
Anandamide (AEA, N-(2-hydroxyethyl)-5Z,8Z,11Z,14Z-eicosatetraenamide), 2-AG ((5Z,8Z,11Z,14Z)-5,8,11,14-eicosatetraenoic acid, 2-hydroxy-1-(hydroxymethyl) ethyl ester), AM251 (N-(piperidin-1-yl)-5-(4-iodophenyl)-1-(2,4-dichlorophenyl)-4-methyl-1H-pyrazole-3-carboxamide), and O2545 hydrochloride ((6aR,10aR)-6a,7,10,10a-tetrahy-
AEA, 2-AG, and AM251 were dissolved in 1:1:18 cremophor/ethanol/saline. AEA, 2-AG, and AM251 (each with 0.5 mg/kg) were applied intravenously (Laviolette and Grace 2006; Lin and Lee 2002) . AEA (and vehicle alone) was also applied by pressure (2.0 mg/ml, Picospritzer II, Science Products GmbH, 5-10 psi).
O2545 hydrochloride was applied iontophoretically (25 mM, pH 3.0 using a Medical Systems Neurophore) using multi-barreled pipettes also filled with 3 M NaCl for recording. Drug application currents were selected on the basis of initial qualitative studies and were applied in a range which did not saturate responses. When not in use, drug barrels were subjected to a retention current of 20 nA of appropriate polarity.
Statistics
Endocannabinoid-induced changes were measured at the time of maximal change in the firing rate after drug administration and were normalized to the control baseline. Only effects that were statistically significant versus control were considered for the analysis (p<0.05 one-way ANOVA or Friedman's tests followed by Dunnett's t test or Wilcoxon's signed rank test when appropriate). Control values were calculated as the mean firing rate of at least two consecutive assessments before drug administration.
Population data were analyzed using one-way ANOVA, Friedman's test, Student's t test, Mann-Whitney's test, or Wilcoxon's signed rank test when appropriate. When necessary, post hoc comparisons were made.
Signal-to-noise ratio In physiology experiments, salience of the stimulus with respect to the background firing (noise) has been considered as a measurement of the signal-tonoise ratio, calculated by dividing the visually evoked response value by the mean spontaneous firing rate for an equivalent time period.
Fano factor (FF) We measured trial-by-trial variability by the FF, which is defined as the variance of the spike count divided by the mean. For each cell, we first obtained the response to the different repeated cycles of a grating stimulus and the spike count was the number of spikes elicited by each stimulus cycle. We obtained a value for each cycle of the visual stimulus from which we calculated variance and mean. Samples included similar time windows in control and drug conditions, in both cases including the whole visual stimulus duration.
Results
We successfully recorded the activity of 66 cells in the dLGN of 27 rats while manipulating CB1 receptor activation. Seven cells had inconsistent properties and were considered too variable to include in this study. The remaining sample included 44/59 (75%) ON center cells and 15/59 (25%) OFF center. Moreover, 37/59 (63%) showed a transient response versus 22/59 (37%) of the cells with clear sustained responses. The visual responses of all 59 cells were significantly altered by compounds manipulating CB1 receptors and no cells were unaffected.
CB1 receptors modulate visual responses
We applied the cannabinoid agonists AEA and 2-AG (n=19 and eight cells, respectively) by intravenous administration, resulting in either significant excitation or inhibition of the visual responses. To illustrate these actions, Fig. 1a shows the response of one dLGN cell to a drifting grating of optimal temporal and spatial frequencies in control (left), 0.5 min after 2-AG injection (center) and recovery (right) after 10 min. During CB1 receptor activation, a significant reduction of Fig. 1b shows a second dLGN cell following AEA injection. In this case, an increase in firing occurred following AEA administration (p<0.05 vs. control, Wilcoxon's signed rank test). These examples typify the two responses. Figure 1c shows the average effects for AEA (left) and 2-AG (right). In both cases, the most common effect was a decrease in the firing rate; this was observed in 84% of the cells during AEA application (16/19 cells) and in 87% of the cells during 2-AG (7/8 cells). Effects were maximal at 1.2±0.52 min after the injection for AEA and 0.9±0.80 min for 2-AG. Recovery time was on average 3.6±0.55 min for AEA and 5.5±1.64 min for 2-AG. Vehicle alone was injected in four cases with no significant effects on neuronal responses (data not shown).
In order to test the selectivity of the observed effect, we injected AEA or 2-AG alone and simultaneously with the selective CB1 receptor antagonist AM251 (n=12 cells). Figure 2a shows the response of a dLGN cell to visual stimulation (left) and how the reduction normally evoked by AEA injection (center) is prevented by AM251 (right), confirming a CB1-mediated action. Summaries of the effect of AM251 on AEA and 2-AG actions are shown in Fig. 2b , c. Interestingly, the administration of the antagonist alone (Fig. 2d) did not significantly affect neuronal response in the cells tested (n=12).
Local application of AEA was tested by pressure ejection to ten cells. This significantly reduced visual responses in 8/10 (80%) of cells and increased visual responses in 2/10 (20%). These shifts in response magnitude were qualitaa b c Fig. 3 PSTHs depicting the effects of CB1 activation by local pressure ejection of AEA on the visual responses of two different dLGN cells (a, b) and the lack of effect of pressure ejection of the vehicle (c). In (a), the visual stimulus was a full field drifting grating with optimal characteristics; spatial frequency was 0.03 c/deg and temporal frequency 1 c/s, with 70-ms bins. In (b), the visual stimulus was a flashed spot of light (0.3 s duration, switched on 0.2 s after the start of the PSTH), bin size 10 ms. In (c), the visual stimulus was a full field drifting grating with optimal characteristics; spatial frequency was 0.03 c/deg and temporal frequency 3 c/s, with 20-ms bins. Ten trials in each case a b Fig. 4 PSTHs showing the visual responses of two dLGN neurons (a, b) to an optimal flashing spot in control situation (left) during the iontophoretic application of O2545 (center) and after a recovery period (right). The upper example shows a clear response increase and the lower a response decrease. In both cases, bin size was 30 ms and p <0.05, Wilcoxon's signed rank test tively and quantitatively similar to those seen using IV administration. The vehicle used for AEA solution was applied alone and shown to be without effect (n=2). These effects are illustrated in Fig. 3 .
We iontophoretically applied the water-soluble synthetic high affinity cannabinoid agonist O2545-hydrochloride to 22 cells. This resulted in either enhanced (11/22) or decreased (11/22) visual responses during application. Enhanced responses were on average 63% greater than predrug control levels (p<0.05, Wilcoxon signed rank test), and decreased responses were on average reduced by 33% compared to the controls (p<0.05, Wilcoxon signed rank test). Effects were demonstrable within 1.0±0.3 min of the start of application. This is illustrated in Fig. 4a, b which show the visual response of two dLGN cells to an optimal flashed spot in control conditions, during application of O2545 and recovery after drug application, the upper records showing a 81% increase and the lower a 56% decrease in visual response magnitude.
As the effects of the agonists were similar whether given locally or systemically, we have combined the data for an overall analysis. The bar histogram in Fig. 5a compares the average magnitudes of the increases or decreases during systemic and local application for the different groups.
The distribution of the effects on visual responses during agonist application is shown for all cells tested in Fig. 5b . This figure most clearly illustrates the existence of two subpopulations with a null between inhibitory (n=42) and excitatory effects (n = 17). This conclusion is further supported by cluster analysis which indicates that two main clusters contain 93.5% of the sample, the first (72%) centered at −41% and the second (21%) centered at +56%. Only the four most extreme positive values were not covered by these clusters. However, although we could clearly identify two populations based upon the polarity of the effect of the drug (increased vs. decreased visual responses), we could find no systematic relationship between this and cell type (on vs. off or sustained vs. transient, see "Discussion").
Relationship between CB1 activation and different visual responses
Given the very clear separation of two response classes shown above, we attempted to dissect out the contribution of CB1 activation to different elements of the visual response, transient vs. sustained; the results were not statistically significant (data not shown). Secondly, we compared responses to static vs. moving visual stimuli (flashed spots vs. drifting gratings). Figure 6 shows the responses of a single dLGN cell to a drifting grating (Fig. 6a) and to a flashing spot (Fig. 6b) . In each case, the stimulus was selected (size, spatial frequency, etc.) to produce a maximal response. In this example, there is a clear reduction in the visual responses during CB1 activation for both stimuli (p<0.05 vs. control, Wilcoxon's signed rank test). The reduction was 52% for the grating and 51% for the spot. For the population, on average (shown in Fig. 6c ), the reduction was 40±3.8% for gratings and 38±3.9% for spots, and the increase was 67±11.2% for gratings and 84±26.8% for spots. Again, these differences were not statistically significant (p>0.05, Student's t test).
Relationship between visual responses and spontaneous activity
Above we reported only significant effects seen on visually driven activity, when cells were activated by appropriate visual stimuli. However, in our overall cell population (n= 59), the effects of manipulation of CB1 receptor-driven activity were qualitatively similar when measured on a b Fig. 5 a The histogram shows the percentage change of the effect with respect to the control values (100%) for IV or local administration of the CB1 agonists (AEA, 2-AG, and O2545, overall n=59). Data are expressed as mean±SEM. b The summary histogram shows the change in visual response resulting from activation of CB1 receptors, as a percentage of the control value, for the whole population of 59 cells. It is clear that there are two distinct populations of cells, separated around zero, i.e., the visual responses of all cells were significantly affected, but were either enhanced (17) or inhibited (42). Cluster analysis (see text) reinforces this conclusion, including all but the extreme right four cells (i.e., 93% of the population) into two clusters visually elicited or spontaneous activity. That is to say, if visual responses were significantly decreased, the spontaneous activity was also significantly decreased, and vice versa. However, the changes in spontaneous activity were significantly greater than effects seen on driven activity, as measured as a percentage of the control levels (Fig. 7a) . Cluster analysis (Fig. 7b ) revealed similar clustering (inhibited, 42 cells, 72% of the population, centered on −59% and excited, 17 cells centered on +109%) to that obtained using evoked responses (see Fig. 5 ). These differential effects on spontaneous and visual evoked responses produced a quantitative change in the ratio between signal amplitude and the level of background activity ("signal-to-noise ratio")-significantly decreased in the case of cells excited by CB1 activation (Fig. 8a, left) and increased in cells inhibited (Fig. 8b, left) . Results of the Fano analysis (which measures "noise" within the visual response) are shown in the right sides of Fig. 8a , b and show significant increases in "within stimulus noise" for cells which showing decreased signal-to-noise during drug action, and the reverse on cells which showed signal-tonoise increases. However, we were most interested to find that spontaneous activity is correlated with the effect of CB1 activation such that the spontaneous activity of cells inhibited by CB1 activation was significantly higher (9±1.2 spikes/s, n=42) than cells excited by CB1 activation (4.27± 1.07 spikes/s, n = 17; p < 0.05, Mann-Whitney test) (Fig. 8c) . This finding "binds together" many of the observations reported above.
Discussion
It is clear that cannabis use can be associated with some visual abnormalities (Kiplinger et al. 1971; Dawson et al. 1977; Russo et al. 2004) . Less clear, however, is the a b c Fig. 6 a Response of a dLGN neuron (ON center) to a grating of optimal characteristics, spatial frequency 0.01 c/deg, temporal frequency 1 c/s in control situation (left), and during iontophoretic application of O2545 (right). b Response of the same neuron as in (a) to a 20°d iameter spot, also in the control situation (left) and during iontophoretic application of O2545 (right). p<0.05 vs. control, Wilcoxon's signed rank test. c Effect of the CB1 agonists tested (AEA, 2-AG, and O2545) during the presentation of spots or gratings of optimal characteristics. Data expressed as mean± SEM mechanism by which the exogenous cannabinoids might affect visual function at a cellular level, specifically considering the early visual pathways. Our data clearly show that exogenous applications of drugs known to activate the endocannabinoid receptor CB1 have significant effects on the visual responsiveness of cells in the rodent dLGN. The data show a clear division in our population with a significant majority of cells showing decreased visual responses, increased signal-to-noise and decreased response variability, and the second lesser population showing the opposite.
Our approach has been to use several different compounds, known to act as agonists at the CB1 receptor, given by several different routes, which together show significant effects on all the dLGN cells tested and confirm that these effects are generated locally within the dLGN and, by the use of the antagonist, are specific to CB1. Although the dorsal thalamus, including the dLGN, shows a low density of CB1 receptors (Herkenham et al. 1991; Pettit et al. 1998; Moldrich and Wenger 2000) , Felder et al. (1996) showed high levels of anandamide (AEA) in the thalamus. This result is supported by high levels of fatty acid amide hydrolase, the degradative enzyme for AEA, in the thalamus (Thomas et al. 1997; Egertová et al. 1998) . Furthermore, it has been shown that the thalamus, despite the moderate expression of CB1 receptors, has a high receptor/G-protein amplification ratio (Breivogel et al. 1997) .
The actual effects we have shown are clearly divided into excitation and inhibition (17/59 and 42/59 cells, respectively), with our sample showing significant changes in both spontaneous and visually elicited activity. In all cases, these changes were of the same polarity for both spontaneous and visually driven spiking. Such a clear division of effects begs the question of what other factor or factors might co-vary with the CB1-mediated effects. For example, cells in the rat dLGN can be subdivided along several lines-physiologically, for example, into Y-like and W-like populations (Hale et al. 1979; Reese 1988) , sustained and transient, or even anatomically/chemically into excitatory (relay) or inhibitory cell types. Inhibitory interneurons are local GABAergic cells and are ∼20% of dLGN cells (Gabbott et al. 1986 ) which can be further differentiated into at least two populations by co-localization of nitric oxide synthase (Gabbott and Bacon 1994) . While it would be interesting if CB1-mediated effects were different on relay versus inhibitory cells, our data do not answer this question. We can say that the full range of visual response types was found in both groups. Further, we did not find any cells in which CB1 induced inhibition changed to excitation during our recording periods and also that both response types were seen in the same animals and within the same penetrations, thereby supporting the view that these are truly separate cell groups.
We also attempted to engage different circuit elements within the visual pathway. Thus, we compared responses to two different visual stimulus paradigms while modulating CB1 activity. Flashing visual stimulation clearly activates retinal input to the thalamus-but while clearly also activating retinal input, drifting, oriented grating stimuli are considered to be more powerful activators of corticofugal input to the dLGN (Cudeiro and Sillito 2006) . Thus, we attempted to activate selectively the sub-families of glutamate receptors associated with retinogeniculate and corticogeniculate afferents (Godwin et al 1996) . However, as clearly illustrated in Fig. 6 , we could find no significant differences between spot and grating responses both including excitation and inhibition, and being equally affected.
However, our data do support some interesting positive results: our populations of cell excited and cells inhibited by CB1 activation are separable if we consider two related elements. At a very simple level, cells which were inhibited by CB1 activation had significantly higher spontaneous firing levels than cells excited. This immediately suggests some form of gain control, but is even more interesting when we compared the magnitude of the drug-induced changes in spontaneous activity with the magnitude of change in visual responses, on a cell-by-cell basis. A very clear shift in the signal-to-noise ratio shows that when CB1 activation decreased the spontaneous activity, the signal-tonoise ratio was significantly increased. That is to say, the visual message given from thalamus to cortex is "cleaned" or "boosted". Furthermore, the decrease in the FF in these cells (a decrease in variability during the visual response) would support this idea. Our population of cells excited by CB1 activation showed opposite characteristics. However, we are at this point unable to say what, if any, other factor (s) might put our cell populations into the high versus low spontaneous firing categories. What is known is that spontaneous activity is directly related to the state of the animal, being significantly higher when the animal is awake (Castro-Alamancos 2004) . A decrease in spontaneous activity within the thalamus may have a direct impact on cortical state, favoring cortical deactivation or synchrony (Hirata and Castro-Alamancos 2010) . Moreover, change in spontaneous activity at the level of the thalamus is able to switch the cortical state (Hirata and Castro-Alamancos 2010) . Thus, our data support a view that the CB1 receptors, rather than favoring a particular "state", may serve to maintain "balance" in an almost homeostatic way, preventing overexcitation or suppression while maintaining information throughput at some defined, perhaps optimal, level. a b c Fig. 8 With this in mind, we note that thalamic cells are involved in multiple neural systems. As noted above, they receive "driving" glutamatergic inputs from the retina, but also modulatory inputs from the visual cortex and, significantly, cholinergic, noradrenergic, and serotonergic inputs (among others) from the brain stem (Steriade et al. 1988 (Steriade et al. , 1997 . These rich modulatory inputs modify neuronal responses at different levels: brainstem inputs are considered to regulate thalamic output globally, changing from sleep to wake (Steriade et al. 1997 ) and inattentive to attentive (Sherman and Koch 1986) , with the cortico-thalamic input appearing to exert a more subtle and specific modulation, for example increasing tight synchrony between cells (Sillito and Jones 2002; Andolina et al. 2007) or modifying the response to specific parts of the stimulus (Rivadulla et al. 2002; Sillito et al. 1993; Cudeiro and Sillito 1996; de Labra et al. 2007 ). In such a complex scenario, endocannabinoids have multiple routes to regulate neuronal function. For example, it is known that AEA and 2-AG can inhibit the release of glutamate or GABA (Schlicker and Kathmann 2001; Piomelli 2003; Wilson and Nicoll 2001; Diana et al. 2002) , i.e., inducing inhibition or excitation, as we see in our data. However, another possibility is an action on cholinergic synapses. CB1 receptor activation can increase or decrease ACh release in the hippocampus (Acquas et al. 2000; Tzavara et al. 2003) with Tzavara et al. (2003) showing that the effect is dose dependent, higher doses having an inhibitory effect. Interestingly, application of the CB1 antagonist AM251 alone, in a dose sufficient to block exogenous agonist activity, did not affect neuronal responses, indicating that endogenous CB release may not be active in local neuronal responses in our anaesthetized preparation, although the CB system may well be an integral part of the "global" modulatory systems arising from the brainstem. In our experimental preparation, the activity of these systems is likely to be significantly depressed (Steriade et al. 1997) , which would be compatible with a low level of CB1 receptor-mediated activity.
On balance, we think that the most plausible explanation for our data may be that in normal physiological function, the endocannabinoid system (through CB1 receptor activation) acts to a greater or lesser degree simultaneously on all three synaptic types, perhaps with each of them having different effects on interneurons or relay cells, with the final result determined by which of the systems is the most relevant at a given time. This would serve to maintain thalamic activity in a middle, moderate range, boosting and clarifying low amplitude signals and avoiding saturation at higher levels. Exogenously applied cannabinoids, as in the "recreational" drug use of cannabis, could clearly disturb this role, giving rise to subtle shifts in thalamocortical inputs to the cortex, in turn affecting higher functions, manifesting in the visual behavioral responses reported in the literature (Kiplinger et al. 1971; Dawson et al. 1977; Russo et al. 2004) .
While more work is necessary to clarify the mechanisms, clearly CB1 receptors are involved in a complex modulation of synaptic communication within the thalamus, previously undescribed, with fundamental consequences for the transfer of sensory information to the cortex.
